Fact CheckerSign in

NCT06754475Recruiting

Effects of Upper Extremity Low Volume HIIT in Heart Failure

The Effect of Upper Extremity Low-Volume High-Intensity Interval Training on Physical and Cognitive Functions in Heart Failure Patients

Source: ClinicalTrials.gov · Last updated 3 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
23 Dec 2024
Start date
1 Nov 2024
Primary completion date
1 Nov 2026
Lead sponsor
Tarsus University
NCT number
NCT06754475

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Nov 2024 to the primary completion date, 1 Nov 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of CABG surgery
  • Unstable angina pectoris
  • Severe arrhythmia
  • Severe left ventricular failure (EF \<40%)
  • History of syncope
  • Orthopedic disorders that may interfere with exercise
  • Uncontrolled hypertension, severe pulmonary arterial hypertension
  • Moderate-severe valve disease
  • Decompensated Congestive Heart Failure

Other

  • Acute pericarditis, endocarditis, myocarditis
  • Acute pulmonary embolism
  • Dissecting aneurysm
  • Thrombophlebitis
  • Electrolyte abnormalities
  • Hypertrophic Cardiomyopathy

Who the study is looking for

  • Clinical condition stable for ≥4 weeks.
  • New York Heart Association functional classification I-II to III
  • Over 18 years old

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tarsus University, TARSUS, Mersin
Coordinator of this site? Confirm its status
MersinTurkey (Türkiye)Recruiting
Nurel Ertürk, TARSUS, Mersin
Coordinator of this site? Confirm its status
YenişehirTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.